Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Official Says Australians Suffer More Sleeping Pill Side Effects Than Other-Country Users

This article was originally published in PharmAsia News

Executive Summary

An Australian government official told a parliamentary committee Australians who take the Sanofi-Aventis drug Stilnox (zolpidem) to sleep appear to suffer far more serious side effects than users in other countries. The Therapeutic Goods Administration said it has been warning about side effects with the drug for the past five years. The drug, marketed in the United States as Ambien, has been linked with bizarre behavior such as sleepwalking and eating while sleeping. The government official said the higher number of Australian cases might be due to a better reporting system in the country. (Click here for more

You may also be interested in...

Dr Reddy's Isolates Data Service Centers Among Preventive Actions Responding To Cyberattack

J&J Faces Fraud Claims From Merger With Surgical Robot Firm

Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.

As Pandemic Boosts Demand For Immunity Supplements, Dentovations Launches Self+ Line

based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts